Literature DB >> 18818904

Brain activation by short-term nicotine exposure in anesthetized wild-type and beta2-nicotinic receptors knockout mice: a BOLD fMRI study.

S V Suarez1, A Amadon, E Giacomini, A Wiklund, J-P Changeux, D Le Bihan, S Granon.   

Abstract

RATIONALE: The behavioral effects of nicotine and the role of the beta2-containing nicotinic receptors in these behaviors are well documented. However, the behaviors altered by nicotine rely on the functioning on multiple brain circuits where the high-affinity beta2-containing nicotinic receptors (beta2*nAChRs) are located.
OBJECTIVES: We intend to see which brain circuits are activated when nicotine is given in animals naïve for nicotine and whether the beta2*nAChRs are needed for its activation of the blood oxygen level dependent (BOLD) signal in all brain areas.
MATERIALS AND METHODS: We used functional magnetic resonance imaging (fMRI) to measure the brain activation evoked by nicotine (1 mg/kg delivered at a slow rate for 45 min) in anesthetized C57BL/6J mice and beta2 knockout (KO) mice.
RESULTS: Acute nicotine injection results in a significant increased activation in anterior frontal, motor, and somatosensory cortices and in the ventral tegmental area and the substantia nigra. Anesthetized mice receiving no nicotine injection exhibited a major decreased activation in all cortical and subcortical structures, likely due to prolonged anesthesia. At a global level, beta2 KO mice were not rescued from the globally declining BOLD signal. However, nicotine still activated regions of a meso-cortico-limbic circuit likely via alpha7 nicotinic receptors.
CONCLUSIONS: Acute nicotine exposure compensates for the drop in brain activation due to anesthesia through the meso-cortico-limbic network via the action of nicotine on beta2*nAChRs. The developed fMRI method is suitable for comparing responses in wild-type and mutant mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818904     DOI: 10.1007/s00213-008-1338-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  58 in total

Review 1.  fMRI: a new tool for the in vivo localization of drug actions in the brain.

Authors:  E A Stein
Journal:  J Anal Toxicol       Date:  2001 Jul-Aug       Impact factor: 3.367

Review 2.  Chronic nicotine administration in the drinking water affects the striatal dopamine in mice.

Authors:  K Pietilä; L Ahtee
Journal:  Pharmacol Biochem Behav       Date:  2000-05       Impact factor: 3.533

Review 3.  Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system.

Authors:  Nicolas Champtiaux; Jean-Pierre Changeux
Journal:  Prog Brain Res       Date:  2004       Impact factor: 2.453

4.  Mapping of presynaptic nicotinic acetylcholine receptors using fluorescence imaging of neuritic calcium.

Authors:  Romain Girod; Mark Jareb; Jason Moss; Lorna Role
Journal:  J Neurosci Methods       Date:  2003-01-30       Impact factor: 2.390

5.  Spatially dissociated flow-metabolism coupling in brain activation.

Authors:  Manouchehr S Vafaee; Albert Gjedde
Journal:  Neuroimage       Date:  2004-02       Impact factor: 6.556

6.  Long-term effects of chronic nicotine exposure on brain nicotinic receptors.

Authors:  Morgane Besson; Sylvie Granon; Monica Mameli-Engvall; Isabelle Cloëz-Tayarani; Nicolas Maubourguet; Anne Cormier; Pierre Cazala; Vincent David; Jean-Pierre Changeux; Philippe Faure
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

7.  Acute and chronic tolerance to nicotine measured by activity in rats.

Authors:  I P Stolerman; R Fink; M E Jarvik
Journal:  Psychopharmacologia       Date:  1973-06-29

Review 8.  Neuronal nicotinic receptors: from structure to pathology.

Authors:  C Gotti; F Clementi
Journal:  Prog Neurobiol       Date:  2004-12       Impact factor: 11.685

9.  NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia.

Authors:  S Kapur; P Seeman
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

10.  Nicotinic modulation of network and synaptic transmission in the immature hippocampus investigated with genetically modified mice.

Authors:  Corentin Le Magueresse; Victoria Safiulina; Jean-Pierre Changeux; Enrico Cherubini
Journal:  J Physiol       Date:  2006-08-10       Impact factor: 5.182

View more
  6 in total

1.  The effects of nicotine exposure and PFC transection on the time-frequency distribution of VTA DA neurons' firing activities.

Authors:  Ting Y Chen; Die Zhang; Andrei Dragomir; Yasemin Akay; Metin Akay
Journal:  Med Biol Eng Comput       Date:  2011-03-30       Impact factor: 2.602

2.  Acute nicotine-induced tachyphylaxis is differentially manifest in the limbic system.

Authors:  Yantao Zuo; Hanbing Lu; D Bruce Vaupel; Yi Zhang; Svetlana I Chefer; William R Rea; Anna V Moore; Yihong Yang; Elliot A Stein
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

3.  Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice.

Authors:  Morgane Besson; Vincent David; Mathieu Baudonnat; Pierre Cazala; Jean-Philippe Guilloux; Christelle Reperant; Isabelle Cloez-Tayarani; Jean-Pierre Changeux; Alain M Gardier; Sylvie Granon
Journal:  Psychopharmacology (Berl)       Date:  2011-09-08       Impact factor: 4.530

4.  Smoking and Neuroimaging: A Review.

Authors:  Hedy Kober; Cameron M Deleone
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-12-01

5.  Genome-wide expression analysis reveals diverse effects of acute nicotine exposure on neuronal function-related genes and pathways.

Authors:  Ju Wang; Wenyan Cui; Jinxue Wei; Dongxiao Sun; Ramana Gutala; Jun Gu; Ming D Li
Journal:  Front Psychiatry       Date:  2011-03-08       Impact factor: 4.157

Review 6.  The power of using functional fMRI on small rodents to study brain pharmacology and disease.

Authors:  Elisabeth Jonckers; Disha Shah; Julie Hamaide; Marleen Verhoye; Annemie Van der Linden
Journal:  Front Pharmacol       Date:  2015-10-21       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.